Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Brazilian (BOVESPA) Pharma Industry Analysis

UpdatedFeb 12, 2025
DataAggregated Company Financials
Companies2
  • 7D0.9%
  • 3M-8.1%
  • 1Y-38.5%
  • YTD7.3%

Over the last 7 days, the Pharma industry has dropped 2.5%, driven by a pullback from Hypera of 2.8%. However, the industry is down 40% over the past year. Looking forward, earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the Brazilian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 12 Feb 2025R$12.8bR$8.7bR$1.7b9.2x7.7x1.5x
Fri, 10 Jan 2025R$12.3bR$8.7bR$1.7b8.6x7.4x1.4x
Sun, 08 Dec 2024R$13.2bR$8.7bR$1.7b10.2x7.9x1.5x
Tue, 05 Nov 2024R$15.5bR$8.9bR$1.7b15.2x8.9x1.7x
Thu, 03 Oct 2024R$17.9bR$8.9bR$1.7b15.3x10.3x2x
Sat, 31 Aug 2024R$19.1bR$8.9bR$1.7b16.7x11x2.1x
Mon, 29 Jul 2024R$19.7bR$9.0bR$1.7b11.1x11.9x2.2x
Wed, 26 Jun 2024R$19.6bR$9.0bR$1.7b10.9x11.8x2.2x
Fri, 24 May 2024R$20.2bR$9.0bR$1.7b11.2x12.1x2.2x
Sun, 21 Apr 2024R$19.1bR$8.9bR$1.6b10.9x12x2.2x
Tue, 19 Mar 2024R$22.5bR$8.9bR$1.6b12.8x14.1x2.5x
Thu, 15 Feb 2024R$21.3bR$9.2bR$1.7b11x12.2x2.3x
Sat, 13 Jan 2024R$23.6bR$9.2bR$1.7b12.6x13.5x2.6x
Mon, 11 Dec 2023R$23.7bR$9.2bR$1.7b12.7x13.6x2.6x
Wed, 08 Nov 2023R$21.0bR$9.2bR$1.8b36.8x11.7x2.3x
Fri, 06 Oct 2023R$23.6bR$9.1bR$1.8b39.1x13.4x2.6x
Sun, 03 Sep 2023R$26.4bR$9.1bR$1.8b42.9x15x2.9x
Tue, 01 Aug 2023R$29.1bR$9.1bR$1.9b13.8x15.7x3.2x
Thu, 29 Jun 2023R$29.0bR$8.8bR$1.8b14.2x16.1x3.3x
Sat, 27 May 2023R$27.4bR$8.8bR$1.8b13.6x15.2x3.1x
Mon, 24 Apr 2023R$24.8bR$8.6bR$1.8b12x13.5x2.9x
Wed, 22 Mar 2023R$26.9bR$8.6bR$1.8b12.7x14.6x3.1x
Fri, 17 Feb 2023R$30.7bR$8.0bR$1.8b14.7x17.4x3.8x
Sun, 15 Jan 2023R$29.5bR$8.0bR$1.8b14.4x16.7x3.7x
Tue, 13 Dec 2022R$27.5bR$8.0bR$1.8b13.3x15.6x3.4x
Thu, 10 Nov 2022R$32.1bR$8.0bR$1.8b15.5x18.3x4x
Sat, 08 Oct 2022R$30.3bR$7.6bR$1.7b14.2x17.3x4x
Mon, 05 Sep 2022R$28.9bR$7.6bR$1.7b13.6x16.5x3.8x
Wed, 03 Aug 2022R$28.2bR$7.6bR$1.8b13.3x16.1x3.7x
Fri, 01 Jul 2022R$25.1bR$7.2bR$1.8b11.7x14.1x3.5x
Sun, 29 May 2022R$25.9bR$7.2bR$1.8b12.5x14.6x3.6x
Tue, 26 Apr 2022R$24.9bR$6.8bR$1.7b12.5x14.4x3.6x
Thu, 24 Mar 2022R$24.3bR$6.8bR$1.7b12.9x14x3.5x
Sat, 19 Feb 2022R$21.9bR$6.3bR$1.7b12.7x13x3.5x
Price to Earnings Ratio

13x


Total Market Cap: R$21.9bTotal Earnings: R$1.7bTotal Revenue: R$6.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Brazilian Pharma Industry Price to Earnings3Y Average 13.5x202320242025
Current Industry PE
    There are only 2 companies in the Brazilian Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 12% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Trends

Which industries have driven the changes within the Brazilian Healthcare industry?

BR Market0.89%
Healthcare2.56%
Pharma0.93%
Pharma0.93%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
HYPE3 HyperaR$19.181.1%
+R$126.5m		-39.8%PE7.7x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

HYPE3

R$19.18

Hypera

7D

1.1%

1Y

-39.8%

OFSA3

R$18.21

Ouro Fino Saúde Animal Participações

7D

-0.5%

1Y

-18.0%